IL100928A - Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis - Google Patents

Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis

Info

Publication number
IL100928A
IL100928A IL10092892A IL10092892A IL100928A IL 100928 A IL100928 A IL 100928A IL 10092892 A IL10092892 A IL 10092892A IL 10092892 A IL10092892 A IL 10092892A IL 100928 A IL100928 A IL 100928A
Authority
IL
Israel
Prior art keywords
lacidipine
arteriosclerosis
prevention
treatment
preparation
Prior art date
Application number
IL10092892A
Other languages
English (en)
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of IL100928A publication Critical patent/IL100928A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL10092892A 1991-02-13 1992-02-12 Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis IL100928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Publications (1)

Publication Number Publication Date
IL100928A true IL100928A (en) 1997-02-18

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10092892A IL100928A (en) 1991-02-13 1992-02-12 Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis

Country Status (23)

Country Link
US (1) US5455257A (it)
EP (2) EP0499920B1 (it)
JP (1) JP2996725B2 (it)
KR (1) KR100188171B1 (it)
AT (1) ATE157004T1 (it)
AU (1) AU646929B2 (it)
CA (1) CA2103805C (it)
CZ (1) CZ281760B6 (it)
DE (1) DE69221649T2 (it)
DK (1) DK0499920T3 (it)
ES (1) ES2106098T3 (it)
GR (1) GR3024661T3 (it)
IE (1) IE920453A1 (it)
IL (1) IL100928A (it)
IT (1) IT1244728B (it)
MX (1) MX9200600A (it)
NO (1) NO303713B1 (it)
PH (1) PH30130A (it)
RU (1) RU2136279C1 (it)
SG (1) SG59972A1 (it)
UA (1) UA27780C2 (it)
WO (1) WO1992014460A1 (it)
ZA (1) ZA921006B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69627137T2 (de) * 1995-06-07 2003-12-04 Ivax Research, Inc. Verwendung von pentosan polysulfat zur behandlung von narben in chronischer fortschreitender gefässerkrankungen
RU2287327C2 (ru) * 2003-10-16 2006-11-20 Юрий Антонович Кошелев Средство для лечения и профилактики атеросклероза
EP1868577A4 (en) * 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
RU2136279C1 (ru) 1999-09-10
HK1009585A1 (en) 1999-06-04
CA2103805A1 (en) 1992-08-14
DK0499920T3 (da) 1998-01-26
UA27780C2 (uk) 2000-10-16
WO1992014460A1 (en) 1992-09-03
AU646929B2 (en) 1994-03-10
NO303713B1 (no) 1998-08-24
KR100188171B1 (en) 1999-06-01
CA2103805C (en) 2002-09-17
ZA921006B (en) 1992-12-30
DE69221649T2 (de) 1997-12-11
GR3024661T3 (en) 1997-12-31
CZ165093A3 (en) 1994-03-16
ATE157004T1 (de) 1997-09-15
DE69221649D1 (de) 1997-09-25
JPH06505002A (ja) 1994-06-09
NO932874D0 (no) 1993-08-12
CZ281760B6 (cs) 1997-01-15
EP0499920A1 (en) 1992-08-26
IT1244728B (it) 1994-08-08
PH30130A (en) 1997-01-21
EP0499920B1 (en) 1997-08-20
US5455257A (en) 1995-10-03
ITMI910359A1 (it) 1992-08-13
EP0576433A1 (en) 1994-01-05
ES2106098T3 (es) 1997-11-01
AU1223192A (en) 1992-09-15
JP2996725B2 (ja) 2000-01-11
NO932874L (no) 1993-08-12
IE920453A1 (en) 1992-08-12
MX9200600A (es) 1992-10-30
SG59972A1 (en) 1999-02-22
ITMI910359A0 (it) 1991-02-13

Similar Documents

Publication Publication Date Title
CA2174338A1 (en) Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
NZ305166A (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments
HUP9700992A3 (en) 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them
ATE121295T1 (de) Augentropfenarzneimittel.
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
NO944531D0 (no) Diaminsalter av clavulansyre
IL100928A (en) Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis
AU3529897A (en) Preventive or therapeutic drug for Alzheimer's disease
AU2081492A (en) Method of controlling dental tartar and compositions for use therein
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
RU93054780A (ru) Применение лацидипина для лечения артериосклероза
EE04235B1 (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
IL97698A0 (en) Hydroxymethyl-indolizidines,quinolizidines and pharmaceutical compositions containing same
EP0351876A3 (en) Composition for potentiating vaccination effect
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions
PL338700A1 (en) Methods of reducing number of thrombocytes in blood
IL70990A0 (en) Pharmaceutical compositions containing glyceryl mononitrates
IL104357A0 (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
IL114562A (en) Alpha-(4-chlorophenyl)-4-((4-fluorophenyl)-methyl) piperidine-1-ethanol esters their preparation and pharmaceutical compositions containing them
NO178093C (no) Anordning for bedring av miljö i munnhulen ved tannbehandling
NZ220868A (en) 2-(aminoalkylthio)methyl-1,4-dihydropyridine derivatives and pharmaceutical compositions
ITMI912425A1 (it) Carbammati utili per il trattamento della demenza senile, procedimento per la preparazione e composizioni farmaceutiche

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees